2022

Articles

• Sýkorová A, Procházka V, Móciková H, Janíková A, Pytlík R, Belada D, Benešová K, Klener P, Ďuraš J, Smolej L, Campr V, Blahovcová P, Trněný M. Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index. Neoplasma. 2022 Dec;69(6):1466-1473. doi: 10.4149/neo_2022_221030N1064. PMID: 36591807.
• Mocikova H, Pytlík R, Benesova K, Janikova A, Duras J, Sykorova A, Steinerova K, Prochazka V, Campr V, Belada D, Trneny M. Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry. Front Oncol. 2022 May 12;12:874462. doi: 10.3389/fonc.2022.874462. PMID: 35646641; PMCID: PMC9133472.
• Janikova A, Michalka J, Chloupkova R, Kopalova N, Campr V, Kamaradova K, Kren L, Belada D, Benesova K, Dlouha J, Klener P, Procházka V, Mocikova H, Duras J, Trneny M. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL). Ann Hematol. 2022 Apr;101(4):789-798. doi: 10.1007/s00277-022-04759-1. Epub 2022 Jan 21. PMID: 35061088.

ASH abstracts

• Vodicka P, Benesova K, Janikova A, Belada D, Mocikova H, Pirnos J, et al. How Relevant Are the Control Cohorts of Clinical Trials in Patients with Newly Diagnosed DLBCL in a Daily Practice? Blood. 2022;140:3775-6.
• Polgarova K, Janíková A, Belada D, Prochazka V, Ďuraš J, Móciková H, et al. Survival of Patients with Primary Mediastinal B-Cell Lymphoma Treated By Immunochemotherapy with or without Radiotherapy. Blood. 2022;140:3831-2.